Published in Blood Weekly, May 13th, 2004
Global Med's Chairman and CEO, Michael I. Ruxin, MD, commenting on the debt restructuring, stated, "This is a very exciting time for Global Med. With the debt restructuring in place, not only have we significantly cleaned up the balance sheet, but our backlog of business continues to grow both domestically and internationally." Dr. Ruxin added, "The company has had positive cash flows for 2 consecutive years and continues to fund its operations from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.